Modifier genes in cystic fibrosis

Area of Science:

• Genetics and Molecular Biology
• Pulmonology
• Gastroenterology

Background:

• Over 1,000 mutations in the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene are known.
• The CFTR gene alone does not fully explain the variable clinical presentation of cystic fibrosis (CF).
• Environmental factors and other genes (non-CFTR) likely contribute to CF pathogenesis.

Purpose of the Study:

• To review current research on genetic modifiers of cystic fibrosis.
• To explore genes influencing CF lung and gastrointestinal manifestations.
• To identify potential targets for novel CFTR-targeted drug development.

Main Methods:

• Literature review of studies investigating genetic and environmental influences on CF.
• Analysis of research focusing on CFTR pathways, including host defense, mucin production, and airway responsiveness.
• Examination of candidate gene studies for gastrointestinal CF manifestations.

Main Results:

• Multiple non-CFTR genes and environmental factors are implicated in CF variability.
• Research has identified genetic influences on both pulmonary and gastrointestinal aspects of CF.
• Understanding these modifiers is crucial for developing effective CF therapies.

Conclusions:

• CFTR mutations are insufficient to explain the full spectrum of cystic fibrosis phenotypes.
• Genetic modifiers and environmental factors play significant roles in CF disease progression.
• Further research into these modifiers is essential for advancing therapeutic strategies and drug development for cystic fibrosis.